Analysis of TP53 Mutations and HBV Genotype D in Liver Cancer from Iran
Author Information
Author(s): Behnoush Abedi-Ardekani, Doriane Gouas, Stephanie Villar, Masoud Sotoudeh, Pierre Hainaut
Primary Institution: International Agency for Research on Cancer
Hypothesis
Is there an association between HBV genotype D and TP53 R249S mutations in hepatocellular carcinoma cases from Iran?
Conclusion
The study found no association between HBV genotype D and TP53 R249S mutations in hepatocellular carcinoma cases from Iran.
Supporting Evidence
- 21 cases of hepatocellular carcinoma were analyzed for specific mutations.
- None of the cases showed the TP53 R249S mutation.
- The predominant HBV genotype in Iran is genotype D.
Takeaway
Researchers looked at liver cancer cases in Iran and found that a specific mutation linked to a virus wasn't common there, which helps explain why liver cancer rates are lower in that region.
Methodology
The study analyzed 21 histologically confirmed hepatocellular carcinoma cases for TP53 R249S and HBV double mutations.
Limitations
The sample size was small and many samples had insufficient quality for complete analysis.
Participant Demographics
{"mean_age":56.4,"sex_distribution":{"men":20,"women":1}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website